Description
The p.K732* pathogenic mutation (also known as c.2194A>T), located in coding exon 19 of the MLH1 gene, results from an A to T substitution at nucleotide position 2194. This changes the amino acid from a lysine to a stop codon within coding exon 19. This alteration occurs at the 3' terminus of theMLH1 gene and is not expected to trigger nonsense-mediated mRNA decay and only impacts the last 25 amino acids of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). This mutation has been previously reported in a woman of Czech ancestry who was diagnosed with colorectal cancer at age 37 and reportedly met Amsterdam criteria as well as a Caucasian women with endometrial cancer at age 31 with corresponding immunohistochemical (IHC) testing (Hajer J et al. Hum. Mutat. 2000 Aug;16(2):181; Latham A et al. J. Clin. Oncol., 2019 02;37:286-295). This mutation has also been observed in a Caucasian woman with a diagnosis of Muir-Torre syndrome due to metachronous colorectal, endometrial, gastric, and sebaceous carcinomas, all of which showed absence of MLH1 protein expression by IHC analysis (Svec J et al. Int J Clin Exp Pathol. 2014 Jul;7(8):5196-202). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.
# | Sample | Method | Observation |
---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
---|
1 | germline | unknown | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |